All products / DC8731
Lesinurad sodium
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $200 USDRequest a quote → |
| 250 mg | $400 USDRequest a quote → |
| 1 g | $800 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
Lesinurad sodium is a URAT1 and OAT inhibitor, is determined to be a substrate for the kidney transporters OAT1 and OAT3 with Km values of 0.85 and 2 µM, respectively.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC8731 |
|---|---|
| Product name | Lesinurad sodium |
| CAS | 1151516-14-1 |
| Molecular formula | C17H13BrN3NaO2S |
| Molecular weight | 426.2628 |
| Purity | >98% |
| SMILES | BrC1=NN=C(N1C1=C([H])C([H])=C(C2=C([H])C([H])=C([H])C([H])=C21)C1([H])C([H])([H])C1([H])[H])SC([H])([H])C(=O)[O-].[Na+] |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Lesinurad sodium (DC8731)Source references
[1]. Shen Z, et al. In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters. Clin Drug Investig. 2016 Jun;36(6):443-52. [2]. Sattui SE, et al. Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. Ther Adv Musculoskelet Dis. 2016 Aug;8(4):145-59. [3]. L.Yeh, et al. RDEA594, a potential uric acid lowering agent througn inhibition of uric acid reuptake ,shows better pharmacokinetics rhan its prodrug RDEA806. 2008 ACR/ARHP Annual Scientific Meeting, 24-29 October 2008, USA.
